1009-3419
2013 Issue 10
tubb3/stmn1 ji yin biao da yu fei xiao xi bao fei ai egfr tong lu de xiang guan xing
Bo WANG;Bin WANG;Lianbin ZHANG;Xiangyang CHU;Gang YU;Department of thoracic surgery;the General Hospital of People’s LiberationArmy;SurExam Bio-Tech Co.Ltd.;
Bo WANG;Bin WANG;Lianbin ZHANG;Xiangyang CHU;Gang YU;Department of thoracic surgery;the General Hospital of People’s LiberationArmy;SurExam Bio-Tech Co.Ltd.;
..............page:547-552
fei lin ai ba xiang zhi liao yan jiu xian zhuang
Hong YUAN;Shun LU;Shanghai Jiao Tong University School of Medicine;Shanghai Lung Tumour Clinical Medical Center;Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University;
Hong YUAN;Shun LU;Shanghai Jiao Tong University School of Medicine;Shanghai Lung Tumour Clinical Medical Center;Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University;
..............page:559-563
..............page:528
ji fei ti ni zhi liao wan qi fei xiao xi bao fei ai nai yao hou de jin zhan mo shi fen xi
Bin WANG;Xin ZHANG;Lin LIN;Xuezhi HAO;Xiangru ZHANG;Junling LI;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences&Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
Bin WANG;Xin ZHANG;Lin LIN;Xuezhi HAO;Xiangru ZHANG;Junling LI;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences&Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
..............page:510-513
pept2 mrna zai fei xian wei hua da shu fei zu zhi zhong de biao da
Li LI;Dianhua WANG;Xuan ZHANG;Xin SONG;Xiaobiao MA;Zaoxiu HU;Department of Bio-immunical Therapy;the Third Affiliated Hospital of Kunming Medical University;Yunnan Phamacological Laboratory of Natural Products;Kunming Medical University;Department of Pathology;the Third Affiliated Hospital of Kunming Medical University;
Li LI;Dianhua WANG;Xuan ZHANG;Xin SONG;Xiaobiao MA;Zaoxiu HU;Department of Bio-immunical Therapy;the Third Affiliated Hospital of Kunming Medical University;Yunnan Phamacological Laboratory of Natural Products;Kunming Medical University;Department of Pathology;the Third Affiliated Hospital of Kunming Medical University;
..............page:541-546
..............page:513
egfr-tki nai yao hou de zhi liao xuan ze
Junling LI;Department of Medical Oncology;Cancer Hospital;Chinese Academy of Medical Science;Peking Union Medical College;
Junling LI;Department of Medical Oncology;Cancer Hospital;Chinese Academy of Medical Science;Peking Union Medical College;
..............page:509
yi fei xian wei hua jiu zhen de yuan fa xing zong zuo jing yuan xi bao liu 1 li
Hong ZHANG;Ying DU;Wei LIU;Baolin WEI;Zengtao SUN;Jiangong HU;Department of Respiratory Medicine;the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine;Department of Pathology;the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine;
Hong ZHANG;Ying DU;Wei LIU;Baolin WEI;Zengtao SUN;Jiangong HU;Department of Respiratory Medicine;the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine;Department of Pathology;the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine;
..............page:564-566
45 li wan qi fei xiao xi bao fei ai egfr-tkis zhi liao huo yi hou chu xian gu li jin zhan hou lian he ju bu zhi liao de hui gu xing fen xi
Xin ZHANG;Bin WANG;Lin LIN;Xuezhi HAO;Shanshan CHEN;Junling LI;Xiangru ZHANG;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences&Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
Xin ZHANG;Bin WANG;Lin LIN;Xuezhi HAO;Shanshan CHEN;Junling LI;Xiangru ZHANG;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences&Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
..............page:514-518
191 li egfr tu bian zhuang tai bu ming wan qi fei xian ai huan zhe egfr-tkis nai yao hou hua liao de liao xiao fen xi
Ping HE;Yan WANG;Sheng YANG;Shufei YU;Ziping WANG;Junling LI;Bin WANG;Xuezhi HAO;Hongyu WANG;Xingsheng HU;Xiangru ZHANG;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences&Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;Department of Hematology and Oncology;Shunyi District Hosipital;China Medical University;
Ping HE;Yan WANG;Sheng YANG;Shufei YU;Ziping WANG;Junling LI;Bin WANG;Xuezhi HAO;Hongyu WANG;Xingsheng HU;Xiangru ZHANG;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences&Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;Department of Hematology and Oncology;Shunyi District Hosipital;China Medical University;
..............page:529-534
egfr-tki zai fei xiao xi bao fei ai zhong nai yao ji zhi de yan jiu jin zhan
Huihui LIU;Mengzhao WANG;Ke HU;Yan XU;Manjiao MA;Wei ZHONG;Jing ZHAO;Longyun LI;Huazhu WANG;Department of Respiratory Medicine;Peking Union Medical College Hospital;Department of Radiotherapy;Peking Union Medical College Hospital;
Huihui LIU;Mengzhao WANG;Ke HU;Yan XU;Manjiao MA;Wei ZHONG;Jing ZHAO;Longyun LI;Huazhu WANG;Department of Respiratory Medicine;Peking Union Medical College Hospital;Department of Radiotherapy;Peking Union Medical College Hospital;
..............page:535-540
egfr-tkis zhi liao wan qi fei xiao xi bao fei ai huo yi hou chu xian huan man jin zhan de zhi liao xuan ze : fu 32 li bing li zong jie
Lin LIN;Bin WANG;Xuezhi HAO;Puyuan XING;Junling LI;Xiangru ZHANG;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences&Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
Lin LIN;Bin WANG;Xuezhi HAO;Puyuan XING;Junling LI;Xiangru ZHANG;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences&Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
..............page:524-528
..............page:567-568
ping guo suan shu ni ti ni zhi liao duo ci fu fa de wan qi fei xiao xi bao fei ai liao xiao yu an quan xing fen xi
Puyuan XING;Junling LI;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Peking Union Medical College&Chinese Academy of Medical Sciences;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
Puyuan XING;Junling LI;Yuankai SHI;Department of Medical Oncology;Cancer Institute/Hospital;Peking Union Medical College&Chinese Academy of Medical Sciences;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
..............page:519-523
di ji liang luo xuan ct fei ai shai cha yan jiu jin zhan
Guanhua REN;Yaguang FAN;Yongcheng ZHAO;Qinghua ZHOU;Peking Union Medical College&Institute of radiation medicine;Chinese Academy of Medical Science;Tianjin Key Laboratory of Lung cancer Metastasis and Tumor Microenvironment;Tianjin Lung cancer Institute;Tianjin Medical University General Hospital;
Guanhua REN;Yaguang FAN;Yongcheng ZHAO;Qinghua ZHOU;Peking Union Medical College&Institute of radiation medicine;Chinese Academy of Medical Science;Tianjin Key Laboratory of Lung cancer Metastasis and Tumor Microenvironment;Tianjin Lung cancer Institute;Tianjin Medical University General Hospital;
..............page:553-558
..............page:518
..............page:523